Santen and UBE Received FDA Approval for OMLONTI® (Omidenepag Isopropyl Ophthalmic Solution) 0.002% for the Reduction of Elevated Intraocular Pressure in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
OMLONTI® is the 2nd FDA-approved product from Santen in the last 15 months for patients in the U.S. with vision...



















